about
Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium?Cellular retinol binding protein-1 expression in endometrial hyperplasia and carcinoma: diagnostic and possible therapeutic implicationsHNF1B and endometrial cancer risk: results from the PAGE study.Endometrial cancer: what is new in adjuvant and molecularly targeted therapy?Switch in FOXA1 status associates with endometrial cancer progressionAssociation between intratumoral lymphatic microvessel density (LMVD) and clinicopathologic features in endometrial cancer: a retrospective cohort study.ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas.Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system.Loss of glutathione peroxidase 3 expression is correlated with epigenetic mechanisms in endometrial adenocarcinoma.Nationwide surveillance in uterine cancer: survival analysis and the importance of birth cohort: 30-year population-based registry in Taiwan.Diagnostic accuracy of preoperative tests for lymph node status in endometrial cancer: a systematic reviewBody mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers.Expression of matrix metalloproteinase-2 and survivin in endometrioid and nonendometrioid endometrial cancers and clinicopathologic significance.Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer.DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer.An immunohistochemical study on the expression of sex steroid receptors, Ki-67 and cytokeratins 7 and 20 in feline endometrial adenocarcinomas.Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium.Molecular staging of gynecological cancer: What is the future?Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer.Biomarkers in endometrial cancer: Possible clinical applications (Review)Pair-Box (PAX8) protein-positive expression is associated with poor disease outcome in women with endometrial cancer.The role of hypoxic-inducible factor (HIF1α) and aldolaseC protein in endometrial carcinogenesis: a retrospective study of 279 patients.Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium.Prognostic significance of reduced immunohistochemical expression of E-cadherin in endometrial cancer-results of a meta-analysis.Coexistence of adenomyosis and endometrioid endometrial cancer: Role in surgical guidance and prognosis estimation.Body mass index, physical activity, and survival after endometrial cancer diagnosis: results from the Women's Health Initiative.Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP Diet and Health Study.CD146 is a potential marker for the diagnosis of malignancy in cervical and endometrial cancerIsolated port-site metastasis after surgical staging for low-risk endometrioid endometrial cancer: A case reportPersonalized care in uterine cancer.Gene expression profiling predicts a three-gene expression signature of endometrial adenocarcinoma in a rat modelMitochondrial ribosomal protein S18-2 is highly expressed in endometrial cancers along with free E2F1.Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma.FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype.Median Survival Time of Endometrial Cancer Patients with Lymphovascular Invasion at the Hospital Universiti Sains Malaysia.Use of mutation profiles to refine the classification of endometrial carcinomas.Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studiesPrognostic role of NF-YA splicing isoforms and Lamin A status in low grade endometrial cancerProblematic issues in the staging of endometrial, cervical and vulval carcinomas.
P2860
Q21261320-851D963E-CF86-45E7-A674-521DE4EA571BQ28304670-DAD9B766-8957-4D8F-90E7-6238AEF91AF9Q31047674-9E28A071-9946-465B-AED4-A6A25ED5982FQ33633962-A3A38A51-9DA6-4743-96CC-10DF662B16F6Q33645463-95AA2179-029D-4409-B405-5E0869496E11Q34244115-3C32357E-A9EE-49D9-8592-F5A3DFF8F857Q34248837-CB9AD3D6-E960-4A7F-A15B-28598613FCC1Q34350701-DB56159A-3E81-485C-8AA9-D8927D79D263Q34443694-5823601D-95EF-4F01-B434-590325DE772FQ34461690-98532470-1497-4FD6-9FDD-4AD592C66FA5Q34516506-8F5374D3-7DCF-4587-BFAA-291ACA22EFA8Q34857343-0402F424-B622-496D-8A03-85FE1F7C28AFQ34883523-637DF342-B630-4056-B795-4F067052D298Q35154536-52AD5154-F9C4-4BF5-9D1A-DC2D20474952Q35510284-E1175BD0-C6A0-43C5-8FFB-AB25F2E4EB6AQ35603652-4E8EA3D5-A9FD-43F4-81F5-BB19134FC9EEQ35744464-3AC2F92C-D7DB-4F92-AF12-01764BA86313Q35909215-6E7BC0B2-0780-4D02-9834-6C0CDDBF908EQ35940829-76FB53AF-7742-466F-8EA4-838A38AE633EQ35971410-F2BE0503-D151-4AFA-AC58-8EE5D540E38BQ36084326-48809617-5961-49FE-8F0C-0151183D2095Q36089953-E7E6A4A9-0E55-442F-91E8-422AA1578661Q36205508-AA74CEBC-E07C-4321-9D60-BBDDC1A0D990Q36379977-79252750-7013-421B-8DB2-418891494EA5Q36411950-A7E40F31-E3D8-4622-BF30-8B141168707FQ36524153-08C4EC67-7062-42FB-939B-22513D4A4405Q36553497-187A248D-F345-4E8B-96C0-80B63619A06DQ36661765-E48F7456-2746-4975-847B-7389BECBD236Q36774284-63A62117-E1B1-4DE4-92B4-75ED630A06BBQ37001087-F37FF004-D579-46F0-A50B-16C0D2A1DE03Q37006856-A53FD43C-AA74-43C5-85CB-F8866D27914AQ37204696-D54553A5-CDE6-4357-8A47-833EB4F07754Q37225495-ED14961C-F94B-42CB-8FE9-3A79617D3E86Q37305478-643228C4-7647-4FAD-9109-0CEB45524ED1Q37486143-5E84C38E-CF06-4863-B542-F77DD576C63AQ37530703-AB4E3AEE-9B0B-46D5-8CFF-00EDE09297A8Q37612253-CBF833DC-C467-4707-A810-C66A2EFDDB9EQ37680720-10AA980D-E576-4EF1-8E8C-12838546867CQ37702641-3DF8FF45-5037-4096-85DC-AB142B67F483Q38067442-EE8C45F6-8CFC-40B8-9F90-12FF40C1B4C5
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Prognostic parameters of endometrial carcinoma.
@ast
Prognostic parameters of endometrial carcinoma.
@en
type
label
Prognostic parameters of endometrial carcinoma.
@ast
Prognostic parameters of endometrial carcinoma.
@en
prefLabel
Prognostic parameters of endometrial carcinoma.
@ast
Prognostic parameters of endometrial carcinoma.
@en
P1433
P1476
Prognostic parameters of endometrial carcinoma.
@en
P2093
Jaime Prat
P304
P356
10.1016/J.HUMPATH.2004.02.007
P407
P577
2004-06-01T00:00:00Z